573 related articles for article (PubMed ID: 23149917)
1. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
2. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
Song SH; Kim KL; Lee KA; Suh W
Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
[TBL] [Abstract][Full Text] [Related]
4. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
6. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
Otani A; Takagi H; Oh H; Koyama S; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1912-20. PubMed ID: 10440243
[TBL] [Abstract][Full Text] [Related]
7. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
8. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tie2 expression by angiopoietin--potential feedback system.
Hashimoto T; Wu Y; Boudreau N; Li J; Matsumoto M; Young W
Endothelium; 2004; 11(3-4):207-10. PubMed ID: 15370298
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
[TBL] [Abstract][Full Text] [Related]
14. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Loges S; Heil G; Bruweleit M; Schoder V; Butzal M; Fischer U; Gehling UM; Schuch G; Hossfeld DK; Fiedler W
J Clin Oncol; 2005 Feb; 23(6):1109-17. PubMed ID: 15718307
[TBL] [Abstract][Full Text] [Related]
15. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
17. Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.
Huang H; Lai JY; Do J; Liu D; Li L; Del Rosario J; Doppalapudi VR; Pirie-Shepherd S; Levin N; Bradshaw C; Woodnutt G; Lappe R; Bhat A
Clin Cancer Res; 2011 Mar; 17(5):1001-11. PubMed ID: 21233403
[TBL] [Abstract][Full Text] [Related]
18. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
[TBL] [Abstract][Full Text] [Related]
19. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
20. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
